| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |